[
  {
    "ts": null,
    "headline": "Nvidia Partners With Biotech Firms On AI Drug Discovery",
    "summary": "Nvidia announced AI partnerships with two biotech firms to transform the way lifesaving drugs are discovered and manufactured.",
    "url": "https://finnhub.io/api/news?id=7c2ace435a4c627ea6bfc01c102eb0c81e23515e03e8aa450aebb2b41279062b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768241156,
      "headline": "Nvidia Partners With Biotech Firms On AI Drug Discovery",
      "id": 138076416,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Nvidia announced AI partnerships with two biotech firms to transform the way lifesaving drugs are discovered and manufactured.",
      "url": "https://finnhub.io/api/news?id=7c2ace435a4c627ea6bfc01c102eb0c81e23515e03e8aa450aebb2b41279062b"
    }
  },
  {
    "ts": null,
    "headline": "NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery",
    "summary": "NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery. News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific discovery.Chai Discovery, Basecamp Research, Boltz and ecosystem leaders connect NVIDIA BioNeM",
    "url": "https://finnhub.io/api/news?id=22172f7ad7a60ecf47acc0bba7207dc5a6b814acf1a019f4edfc41e3643ce9b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768230000,
      "headline": "NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery",
      "id": 138075089,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery. News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific discovery.Chai Discovery, Basecamp Research, Boltz and ecosystem leaders connect NVIDIA BioNeM",
      "url": "https://finnhub.io/api/news?id=22172f7ad7a60ecf47acc0bba7207dc5a6b814acf1a019f4edfc41e3643ce9b0"
    }
  },
  {
    "ts": null,
    "headline": "TetraScience Announces Collaboration with Thermo Fisher Scientific to Accelerate Scientific Data and AI Enablement Across the Laboratory",
    "summary": "TetraScience, the Scientific Data and AI company, today announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a goal of accelerating AI across biopharma R&D and manufacturing by transforming scientific data into AI-native form and developing intelligent workflows at scale.",
    "url": "https://finnhub.io/api/news?id=786fcfd2a11f4586960abe3c2fedeaf819253f99e29378c8019e17405f165100",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768230000,
      "headline": "TetraScience Announces Collaboration with Thermo Fisher Scientific to Accelerate Scientific Data and AI Enablement Across the Laboratory",
      "id": 138075239,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "TetraScience, the Scientific Data and AI company, today announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a goal of accelerating AI across biopharma R&D and manufacturing by transforming scientific data into AI-native form and developing intelligent workflows at scale.",
      "url": "https://finnhub.io/api/news?id=786fcfd2a11f4586960abe3c2fedeaf819253f99e29378c8019e17405f165100"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company",
    "summary": "Thermo Fisher Scientific’s number-two executive, Michel Lagarde, is leaving the life-sciences giant to pursue another opportunity.",
    "url": "https://finnhub.io/api/news?id=7a5c49c817ad98b4ddab1c3adf59b4e07c5678d446ba37b880a61196d4b79cd7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768219680,
      "headline": "Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company",
      "id": 138072367,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific’s number-two executive, Michel Lagarde, is leaving the life-sciences giant to pursue another opportunity.",
      "url": "https://finnhub.io/api/news?id=7a5c49c817ad98b4ddab1c3adf59b4e07c5678d446ba37b880a61196d4b79cd7"
    }
  },
  {
    "ts": null,
    "headline": "Henry Schein Names Frederick M. Lowery as Chief Executive Officer",
    "summary": "MELVILLE, N.Y., January 12, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer (\"CEO\"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and ef",
    "url": "https://finnhub.io/api/news?id=230c7a0d54e1542b4b4f452578fa94151f3f60b68241c66be09130a71a57e2e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768219200,
      "headline": "Henry Schein Names Frederick M. Lowery as Chief Executive Officer",
      "id": 138071432,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "MELVILLE, N.Y., January 12, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer (\"CEO\"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and ef",
      "url": "https://finnhub.io/api/news?id=230c7a0d54e1542b4b4f452578fa94151f3f60b68241c66be09130a71a57e2e1"
    }
  }
]